ACOI was honored to help support Dr. Kwon’s nomination to PACCARB. “Dr. Kwon has an impressive track record of antimicrobial resistance research (AMR),” said ACOI President Robert T. Hasty, DO, FACOI, FACP. “PACCARB is fortunate to have the value of her expertise, including her work on strategies to prevent transmission of AMR.”

The CY 2024 Medicare Physician Fee Schedule (PFS) final rule released on November 3 finalizes a 2024 conversion factor — the starting point for calculating physician payments — of $32.74, a decrease of $1.15 (or 3.37%) from the CY2023 conversion factor of $33.89. Roughly 90 percent of the cut is attributed to fee schedule budget neutrality requirements triggered by the impending January 1, 2024, implementation of G2211, an office/outpatient evaluation and management visit complexity add-on code.

The American College of Osteopathic Internists Board of Directors welcomes its new Resident Representative, John A. Arthur, DO.